BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)-MedSci.cn

BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)

Werth, V; Furie, R; Romero-Diaz, J; Navarra, S; Kalunian, K; Van Vollenhoven, R; Nyberg, F; Kaffenberger, B; Sheikh, S; Radunovic, G; Huang, X; Carroll, H; Gaudreault, F; Meyers, A; Barbey, C; Musselli, C; Franchimonton, N

ANNALS OF THE RHEUMATIC DISEASES, 2020; 79 (): 120

科室
- - 订阅+
  - 更多科室
工具
服务